Stock NSIS B NOVONESIS A/S
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Novonesis A/S

Equities

NSIS B

DK0060336014

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:39 2024-04-26 am EDT 		5-day change 1st Jan Change
389.6 DKK +1.27% Intraday chart for Novonesis A/S +0.67% +4.99%
Apr. 08 Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023 CI
Mar. 26 China to speed up 'new productive forces', vice president says RE

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Novozymes A/S Proposes Dividend for the Last Four Months Ended December 31, 2023
CI
Novonensis expects 2024 adjusted EBITDA margin of 35%
RE
Novonesis Provides Earnings Guidance for the Year 2024
CI
Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development
MT
Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG
CI
FMC Partners With Novonesis in Canada for Biosolution Products
MT
Novonesis to Unveil Fit-for-Food Mood-Support Probiotic at Natural Product Expo West
CI
Novo Nordisk's controlling shareholder plans to invest about $35 billion by 2030
RE
Novozymes A/S Reports Earnings Results for the Full Year Ended December 31, 2023
CI
NOVOZYMES : Q4 23: destocking noise offsets recovery in other key segments
Alphavalue
Novozymes, Chr. Hansen Complete Merger Settlement
MT
Novozymes Completes Merger with Chr. Hansen After Securing Final Registration, Issuing B Shares
MT
Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S.
CI
Novozymes, Chr. Hansen’s Proposed Merger Secures All Regulatory Approvals
MT
Novozymes, Chr. Hansen Merger Wins Korean Regulatory Nod
MT
Celadon Pharma raises GBP2.0 million via placing
AN
Novozymes-Chr. Hansen Merger Gets EU Nod After Proposed Asset Sale
MT
Kerry Group Buys Novozymes, Chr. Hansen Assets for EUR150 Million
DJ
Kerry Group to buy lactase business for EUR150 million
AN
Kerry Group plc agreed to acquire Lactase enzyme business from Chr. Hansen Holding A/S and Novozymes A/S (CPSE:NZYM B) for ?150 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NSIS B Stock
  4. News Novonesis A/S
  5. Highlights